Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12.4Revenue $M0.1Net Margin (%)-19,022.4Z-Score-21.7
Enterprise Value $M8.4EPS $-50.8Operating Margin %-16,055.3F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-19,021.1Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %0Quick Ratio7.7Cash flow > EarningsN
Price/Sales23.35-y EBITDA Growth Rate %0Current Ratio7.8Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-195.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-1,998.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M4.5ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BIOC

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BIOC is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BIOC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BERG JEFFREY HDirector 2012-03-07Sell5,000$5.55-49.73view
LoCastro MarcellaDirector 2011-12-16Buy1,500$4.49-37.86view
LoCastro MarcellaDirector 2011-12-15Buy1,750$4.45-37.3view
PARKER WALLACE P JRDirector 2011-12-07Buy1,000$4.25-34.35view
PARKER WALLACE P JRDirector 2011-12-05Buy3,000$4.37-36.16view
PARKER WALLACE P JRDirector 2011-11-22Buy1,000$4.4-36.59view
PARKER WALLACE P JRDirector 2011-03-15Buy400$4.64-39.87view
PARKER WALLACE P JRDirector 2011-03-14Buy1,600$4.64-39.87view
PARKER WALLACE P JRDirector 2011-03-10Buy1,200$4.64-39.87view
PARKER WALLACE P JRDirector 2011-03-01Buy2,000$4.97-43.86view

Press Releases about BIOC :

    Quarterly/Annual Reports about BIOC:

    News about BIOC:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Nasdaq stocks posting largest volume increases Dec 17 2014
    Biocept's Patented Platform Identifies Clinically HER2-Negative Patients With HER2-Positive... Dec 17 2014
    8:32 am Biocept patented platform identifies clinically HER2-negative patients with HER2-positive... Dec 17 2014
    Biocept's Patented Platform Identifies Clinically HER2-Negative Patients With HER2-Positive... Dec 17 2014
    Biocept Expands Worldwide Microchannel Patent Protection to South Korea Dec 15 2014
    Biocept Expands Worldwide Microchannel Patent Protection to South Korea Dec 15 2014
    Biocept Appoints Experienced Physician as Medical Director Dec 03 2014
    Biocept Appoints Experienced Physician as Medical Director Dec 03 2014
    BIOCEPT INC Financials Nov 22 2014
    BIOCEPT INC Files SEC form 10-Q, Quarterly Report Nov 14 2014
    Biocept Reports Third Quarter 2014 Financial Results Nov 13 2014
    BIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 13 2014
    Biocept Reports Third Quarter 2014 Financial Results Nov 13 2014
    Biocept Launches Lung Cancer Offering Nov 12 2014
    Biocept Launches Lung Cancer Offering Nov 12 2014
    Biocept, Inc. Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results Nov 06 2014
    Biocept, Inc. Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results Nov 06 2014
    Biocept and Rosetta Genomics Collaborate to Evaluate microRNAs From Circulating Tumor Cells Oct 13 2014
    Biocept Expands Collaboration With MD Anderson Cancer Center Oct 07 2014
    Biocept to Present at the 13th Annual BIO Investor Forum Sep 30 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK